NFKB1 and Duchenne muscular dystrophy: In placebo-controlled, double-blind, randomized trials carried out in DMD patients, treatment with EPA and docoshexaenoic acid (DHA) reduced inflammation markers and diminished the expression of NF-κB in leukocytes [76,77].